LVRC IDE Crossover Study (Crossover From IDE Trial CLN0009)

NATerminatedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

June 30, 2017

Study Completion Date

July 26, 2019

Conditions
Emphysema
Interventions
DEVICE

LVRC System

Trial Locations (25)

10032

New York Presbyterian Columbia University Medical Center, New York

15213

Emphysema COPD Research Center, University of Pittsburgh, Pittsburgh

19140

Temple, Philadelphia

27710

Duke University Medical Center, Durham

32610

University of Florida, Gainesville

35294

University of Alabama Lung Health Center, Birmingham

44195

The Cleveland Clinic, Cleveland

48109

University of Michigan Health System, Ann Arbor

51092

CHU de Reims - Hopital Maison Blanche, Reims

53792

University of Wisconsin School of Medicine & Public Health, Madison

55905

Mayo Clinic, Rochester

60611

Northwestern University, Chicago

61606

Illinois Lung and Critical Care Institute, Peoria

77030

Pulmonary, Critical Care & Sleep Medicine Consultants,PCCS/St. Luke's Episcopal Hospital, Houston

90048

Cedars Sinai Medical Center, Los Angeles

94040

El Camino Hospital/Palo Alto Medical Foundation, Mountain View

98405

Franciscan Research Center, Tacoma

06510

Yale University School of Medicine - Yale New Haven Hospital, New Haven

02215

Beth Israel Deaconess Medical Center, Boston

29425-6300

Medical University of South Carolina, Charleston

78229-3900

University of Texas Health Sciences Center at San Antonio, San Antonio

Unknown

Institut Universitaire de Cardiologie et de Pneumologie de Quebec (IUCPQ), Québec

CS 51069

Centre Hospitalier Universitaire de Nice, Nice

3150-3610536

University Medical Center Groningen, Groningen

SW3 6NP

Royal Brompton Hospital & Chelsea Westminster, London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

PneumRx, Inc.

INDUSTRY

lead

Boston Scientific Corporation

INDUSTRY

NCT02059057 - LVRC IDE Crossover Study (Crossover From IDE Trial CLN0009) | Biotech Hunter | Biotech Hunter